Literature DB >> 19783781

Altered reactivity to norepinephrine through COX-2 induction by vascular injury in hypercholesterolemic rabbits.

Nabil Foudi1, Xavier Norel, Mario Rienzo, Liliane Louedec, Charles Brink, Jean-Baptiste Michel, Magnus Bäck.   

Abstract

Although long-term use of cyclooxygenase (COX)-2 inhibitors may be associated with increased cardiovascular risk, their effects on vascular reactivity in atherosclerosis has remained largely unexplored. The aim of the present study was to evaluate the role of COX-2 induced by an atherosclerotic process, in the local control of vascular tone. New Zealand White rabbits were fed 0.3% cholesterol and subjected to balloon injury of the abdominal aorta. After 2 wk, the aorta was removed and used for organ bath experiments and immunohistochemistry, and the prostaglandins released were measured using enzyme immunoassays. Hypercholesterolemia and vascular injury significantly increased the thickness of the intimal layer, which was associated with an induction of COX-2 immunoreactivity throughout the aortic wall. In these preparations, a significant decrease of the maximal contractions induced by norepinephrine was observed. The norepinephrine-induced contractions of atherosclerotic preparations were restored by the COX inhibitors DuP-697 (0.5 micromol/l) and indomethacin (1.7 micromol/l), to similar contractions as was observed in aortic preparations derived from healthy rabbits. Norepinephrine stimulation of the abdominal aorta was accompanied by increased levels of prostaglandin I(2) but not of prostaglandin E(2), prostaglandin D(2), or thromboxane A(2) in atherosclerotic compared with normal aorta. Selective COX-2 inhibition significantly decreased the prostaglandin I(2) release from atherosclerotic aorta but had no effect on the prostaglandin release from aortic preparations derived from normal rabbits. These observations suggest that the local induction of COX-2 during atherosclerosis decreased the sensitivity to norepinephrine and that COX-2 inhibitors may increase vascular reactivity at sites of atherosclerotic lesions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19783781     DOI: 10.1152/ajpheart.00092.2009

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  4 in total

Review 1.  The role of matrix metalloproteinases in atherothrombosis.

Authors:  Daniel F J Ketelhuth; Magnus Bäck
Journal:  Curr Atheroscler Rep       Date:  2011-04       Impact factor: 5.113

Review 2.  Anti-inflammatory therapies for atherosclerosis.

Authors:  Magnus Bäck; Göran K Hansson
Journal:  Nat Rev Cardiol       Date:  2015-02-10       Impact factor: 32.419

3.  Impaired acetylcholine-induced endothelium-dependent aortic relaxation by caveolin-1 in angiotensin II-infused apolipoprotein-E (ApoE-/-) knockout mice.

Authors:  Sai Wang Seto; Smriti M Krishna; Hongyou Yu; David Liu; Surabhi Khosla; Jonathan Golledge
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

4.  Influence of celecoxib on the vasodilating properties of human mesenteric arteries constricted with endothelin-1.

Authors:  Grzegorz Grześk; Katarzyna Szadujkis-Szadurska; Grzegorz Matusiak; Bartosz Malinowski; Marta Gajdus; Michał Wiciński; Leszek Szadujkis-Szadurski
Journal:  Biomed Rep       Date:  2014-01-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.